novo nordisk - Search News

News

Novo Nordisk slashes price of Ozempic

Novo Nordisk slashes price of weight loss drugs

Novo Nordisk is teaming up with GoodRx to offer Wegovey and Ozempic for a flat price of $499 a month. Top Air Force general to exit in Hegseth’s latest shake-up of Pentagon

NBC New York · 14h

Novo Nordisk slashes price of Ozempic to $499 for cash-paying, uninsured patients

Novo Nordisk is slashing the price of its blockbuster diabetes drug Ozempic for U.S. patients who self-pay or are uninsured.

NJBIZ · 9h

Novo Nordisk halves Ozempic price to $499 for US patients

Novo Nordisk lowers Ozempic cost to $499 per month for uninsured U.S. patients, expanding access through NovoCare and 70,000 pharmacies.

Novo Nordisk shares pop

Reuters on MSN · 1d

Shares in Novo Nordisk rise after Wegovy gets US nod for liver disease treatment

Shares in Novo Nordisk rose on Monday, after it got U.S. approval for its weight-loss drug Wegovy to treat a serious liver condition, positive news for the drugmaker that lost more than one-third of its market value in recent weeks.

The Wall Street Journal · 1d

FDA Approves Novo Nordisk’s Wegovy for Liver Disease

Novo Nordisk shares climbed after the U.S. Food and Drug Administration approved a new indication for the Danish drugmaker’s blockbuster Wegovy medicine to treat a serious fatty liver disease.

MarketWatch on MSN · 1d

Novo Nordisk shares are rising. The FDA approves another use for Wegovy.

Novo Nordisk shares rose 4% in Copenhagen trade. The stock however has plunged 46% this year amid increased competition for its weight-loss drugs as well as turmoil at the company

7hon MSN

Novo Nordisk, GoodRx selling Ozempic at half cost for customers paying cash

Novo Nordisk and GoodRx announced a partnership this week to sell products Ozempic and Wegovy at half their normal cost to ...

19hon MSN

Home Depot disappoints, Novo Nordisk's GLP-1 updates, an AI warning and more in Morning Squawk

Home Depot kicked off this week's string of retailer earnings reports. Novo Nordisk provided two major updates on its ...

Stocks to Watch Monday: Novo Nordisk, TeraWulf, UnitedHealth, Soho House

The Food and Drug Administration approved Novo Nordisk's popular weight-loss drug Wegovy to treat a form of liver disease.

From Doubt To Action: Why I Bought Novo Nordisk After Earnings

Novo Nordisk A/S innovation and growth continue to shine. Now, it has a partnership with GoodRX Holdings. Click for my ...

AOL15h

Why Novo Nordisk Stock Popped Today

That's a better result than Eli Lilly just reported for its GLP-1 pill, but not quite as good as what Novo Nordisk reports.

1don MSN

GoodRx stock soars after striking deal to sell Novo Nordisk's GLP-1s for $499/month

GoodRx is joining the GLP-1 action with an announcement Monday to begin selling both Novo Nordisk's GLP-1 drugs, Ozempic and ...

Novo Nordisk: Negative Streak Finally Ended

The string of negative updates from Novo Nordisk and positive news flow from the main competitor Eli Lilly has finally ended ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results